Search

Your search keyword '"Schechter, Meir"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Schechter, Meir" Remove constraint Author: "Schechter, Meir" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
32 results on '"Schechter, Meir"'

Search Results

3. Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial

7. Normoalbuminuria—is it normal? The association of urinary albumin within the 'normoalbuminuric' range with adverse cardiovascular and mortality outcomes: A systematic review and meta‐analysis.

13. Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of Frailty.

15. Risk of hospitalization with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes lacking evidence of chronic kidney disease: Real‐world data.

16. Dapagliflozin and Anemia in Patients with Chronic Kidney Disease.

17. Medical cannabis for pain management in patients undergoing chronic hemodialysis: randomized, double-blind, cross-over, feasibility study.

18. Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease : A Post Hoc Analysis of DAPA-CKD.

19. Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS.

20. Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial.

21. Preventing all‐cause hospitalizations in type 2 diabetes with sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A narrative review and proposed clinical approach.

22. Prediction of the Effects of Liraglutide on Kidney and Cardiovascular Outcomes Based on Short-Term Changes in Multiple Risk Markers.

23. An Emerging Role for Phosphoinositides in the Pathophysiology of Parkinson's Disease.

24. Adolescent Thyroid Disorders and Risk for Type 2 Diabetes in Young Adulthood.

25. The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58.

26. α-Synuclein facilitates endocytosis by elevating the steadystate levels of phosphatidylinositol 4,5-bisphosphate.

27. Loss of Corticostriatal Mu-Opioid Receptors in α-Synuclein Transgenic Mouse Brains.

28. Total and Proteinase K-Resistant α-Synuclein Levels in Erythrocytes, Determined by their Ability to Bind Phospholipids, Associate with Parkinson's Disease.

29. Medical cannabis for pain management in patients undergoing chronic hemodialysis: randomized, double-blind, cross-over, feasibility study.

30. [IMPROVEMENT OF RENAL OUTCOMES WITH SODIUM-GLUCOSE COTRANSPORTER-2 (SGLT2) INHIBITORS].

32. Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial.

Catalog

Books, media, physical & digital resources